Crescent Biopharma, Inc. · NASDAQ:CBIO
Peter Harwin reported a 16.52% stake in Crescent Biopharma, Inc. (Schedule 13D/A)
Event Jul 16, 2026 · Filed Jul 20, 2026
Peter Harwin reported a 16.52% stake in Crescent Biopharma, Inc., 6,602,408 shares, with active intent on Jul 16, 2026. Filed Jul 20, 2026 (Schedule 13D/A).
- Stake
- 16.52%
- Shares
- 6,602,408
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Fairmount Funds Management LLC | 16.50% | 6,593,385 |
| Fairmount Healthcare Fund II L.P. | 16.50% | 6,593,385 |
| Peter Harwin | 16.52% | 6,602,408 |
| Tomas Kiselak | 16.50% | 6,593,385 |